Top Markets
Coin of the day
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
株式のランク #16730
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
株価
$3.78
最終同期: 2026-03-17
時価総額
$276.54M
変化(1日)
0.00%
変化(1年)
45.53%
CA
取引 NervGen Pharma Corp. (NGEN)

カテゴリー

NervGen Pharma Corp.(NGEN)の株価履歴
終値の最高値: $3.98 (2026-03-01)

終値の最安値: $1.12 (2019-03-01)
NervGen Pharma Corp. の株価履歴(2019 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -18.31%
2025 129.35%
2024 42.00%
2023 15.06%
2022 -43.93%
2021 48.46%
2020 21.58%
2019 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.24 -10.01%
AU
$748.60 6.90%
CH